Neuros Medical Achieves First Implant of Altius® System for Chronic Pain Relief

Neuros Medical has announced the first commercial use of its Altius® Direct Electrical Nerve Stimulation System in the United States, marking a significant step forward in treating chronic post-amputation pain. 

The system, recently approved by the U.S. Food and Drug Administration (FDA), was implanted in a patient at Baylor Scott & White Heart and Vascular Hospital.

The Altius System is designed for adult patients with lower limb amputations who suffer from persistent, hard-to-treat phantom or residual limb pain.

It offers an alternative to opioid medications by using on-demand electrical nerve stimulation to block pain signals before they reach the brain.

The system features a cuff electrode positioned around a peripheral nerve close to the amputation area, along with an implantable pulse generator (IPG).

Patients control the device themselves, activating a 30-minute session as needed to relieve pain. 

This method aims to offer more sustainable pain management, particularly for those who have not responded to conventional treatments.

With more than two million people in the United States living with major limb amputations, and around 80% believed to suffer from chronic pain related to their amputation, the need for effective non-opioid treatment options remains high.

The Altius System is intended for adult lower limb amputees experiencing chronic, treatment-resistant phantom or residual limb pain.

It remains the only system of its kind offering patient-controlled, targeted pain relief through direct nerve stimulation.